Observational Study Evaluating Rituximab Use and Use of the Patient Alert Card in Participants Receiving Rituximab Infusion for a Non-Oncology Indication at Infusion Centers in Europe

CompletedOBSERVATIONAL
Enrollment

1,408

Participants

Timeline

Start Date

December 18, 2015

Primary Completion Date

September 29, 2017

Study Completion Date

September 29, 2017

Conditions
Off-Label Use
Interventions
BIOLOGICAL

Rituximab

Rituximab use in non-oncology indications

Trial Locations (48)

10154

Ospedale San Giovanni Bosco, Turin

15006

Complejo Hospitalario Universitario A Coruña, A Coruña

18012

Hospital Universitario San Cecilio, Granada

20122

Asst Centro Specialistico Ortopedico Traumato-Logico Gaetano Pini/Cto, Milan

20132

Ospedale San Raffaele, Milan

23538

Universitätsklinikum Schleswig-Holstein; Campus Lübeck, Lübeck

28040

Hospital Universitario Clínico San Carlos, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

29009

Hospital Regional Universitario de Malaga; Servicio de Reumatologia, Málaga

31059

CHU de Toulouse - Hôpital Purpan, Toulouse

33600

Groupe Hospitalier Sud - Hôpital Haut-Lévêque - Centre François Magendie, Pessac

34295

Hôpital Lapeyronie, Montpellier

36214

Hospital Meixoeiro, Vigo

39245

Fachkrankenhaus Vogelsang, Vogelsang-Gommern

40878

Rheumazentrum Ratingen - Studienambulanz, Ratingen

41071

Hospital Universitario Virgen Macarena, Seville

42055

CHU Saint-Etienne, Hopital Bellevue, Saint-Etienne

44093

CHU NANTES - Hôtel Dieu; Pharmacy, Nantes

44100

Azienda Ospedaliera Universitaria Arcispedale S. Anna, Ferrara

47005

Hospital Clinico Universitario Valladolid, Valladolid

50141

Azienda Ospedaliera Universitaria Careggi, Florence

53100

A.O.U. Senese Policlinico Santa Maria Alle Scotte, Siena

55101

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz

56100

Azienda Ospedaliero Universitaria Pisana, Pisa

59037

Hopital Claude Huriez - CHU Lille, Lille

60528

CIRI - Centrum für Innovative Diagnostik und Therapie GmbH, Frankfurt

63003

Chu De Clermont Ferrand; Hopital Gabriel Montpied, Clermont-Ferrand

69120

Universitätsklinikum Heidelberg, Heidelberg

72037

Centre Hospitalier Le Mans, Le Mans

75014

Hôpital Cochin, Paris

79106

Universitaetsklinikum Freiburg; Innere Medizin II, Gastroenterologie, Freiburg im Breisgau

91106

Centre Hospitalier Sud Francilien, Corbeil-Essonnes

01067

Krankenhaus Dresden-Friedrichstadt, Dresden

06128

Private Practice Dr. A. Liebhaber, Halle

00167

IDI-Istituto Dermopatico dell'Immacolata IRCCS, Rome

09131

Azienda Ospedaliera Giuseppe Brotzu, Cagliari

08208

Corporacio Sanitaria Parc Tauli, Sabadell

08041

Hospital de la Santa Creu i Sant Pau, Barcelona

08907

Hospital Universitari de Bellvitge; Servicio de Reumatologia, Barcelona

BS2 8HW

Bristol Royal Infirmary, Bristol

CB2 0QQ

Addenbrooke's Hospital, Cambridge

C03 3NB

Southend University Hospital, Colchester

EX2 5DW

Royal Devon and Exeter Hospital (Wonford), Exeter

PL6 8DH

Derriford Hospital, Plymouth

M6 8HD

Salford Royal, Salford

TQ2 7AA

Torbay Hospital, Torquay

TR1 3LQ

Royal Cornwall Hospital, Truro

WV10 0QP

New Cross Hospital, Wolverhampton

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02654379 - Observational Study Evaluating Rituximab Use and Use of the Patient Alert Card in Participants Receiving Rituximab Infusion for a Non-Oncology Indication at Infusion Centers in Europe | Biotech Hunter | Biotech Hunter